Is Sanofi-Aventis Expecting Resistance?

Published on Tuesday, 19 June 2012 09:08 Written by TradersHuddle Wire

New York, June 19th (TradersHuddle.com) - Sanofi-Aventis (NYSE:SNY) closed the the trading session at $35.47, near its 50 day and 200 day moving averages currently set at $35.76 and $35.65 respectively. Sanofi-Aventis' price action places the stock below these important levels, which makes it difficult to be bought, as it will certainly face resistance as it approaches these important moving averages.

Sanofi-Aventis (NYSE:SNY) is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

The latest price action range, defined by a peaks and troughs algorithm, placed calculated support at $33.03 and resistance at $38.76. Traders should monitor these levels, as they provide insight into the latest price dynamics in Sanofi-Aventis .

If traders want to establish a position on Sanofi-Aventis , given the heavy resistance expected near the 50 and 200 day moving averages, a trade might be evident as the stock manages to break these moving averages. However, until the break materializes buying the stock is nothing different than flipping a coin.